Anipryl is only for dogs with senility
or canine Cushing's Disease. Not for human use. Do not give to cats
or other animals. Only for dogs with a prescription.
Keep out of reach of children. Do not
allow children to administer or otherwise handle Anipryl. Read directions
and precautionary statements before use.
The following directions represent
a standard use. Use exactly as prescribed by your veterinarian.
Directions:
- Remove only one dose from
the blister pack. Return the remaining medication to its safe storage
location.
- Give your dog a dose of
0.2-0.45 mg per pound of body weight in the morning when treating for
canine cognitive dysfunction.
- Give your dog a dose of
0.45 per pound of body weight in the morning when treating for canine
Cushing's Disease.
- Double the dose to 0.9 mg
per pound if dogs with Cushing's disease show no results after 2 months
of treatment.
- Observe your dog to ensure
consumption of the full oral dose.
Your veterinarian will monitor your
dog and may adjust the dosage until a proper dose is found. Your dog
and the dosage will be reevaluated periodically. Dogs with Cushing's
Disease that show no improvement after 1 month at the doubled dosage
should be reevaluated.
Frequency of Use:
Anipryl is administered once a day,
preferably in the morning.
If you miss a dose and it is more than
16 hours until the next day's scheduled dose, give your dog the tablet
as soon as you remember. If you miss a dose and there is less than 16
hours until the next regularly scheduled dose, skip the dose and resume
the normal schedule the next day. Never give a double dose of Anipryl.
Storage:
Store in original container and out
of reach of children and animals.
Store Anipryl at controlled room temperature,
from 68-77 degrees F. Protect this product from heat and moisture.
It is a violation of Federal Law
to use this product in a manner inconsistent with its labeling.
Selegiline, the active ingredient in
Anipryl, is a monoamine oxidase inhibitor (MAOI). It boosts a dog's
dopamine concentration, enhancing cognitive functions to combat the
effects of senility. Anipryl treats canine Cushing's Disease by suppressing
the pituitary gland to reduce cortisone.
Anipryl is available only by prescription
from your veterinarian.
Anipryl is sold in packages containing
one blister pack of 30 oral tablets. It is available in five dosages:
2 mg, 5 mg, 10 mg, 15 mg, and 30 mg.
Warnings:
Keep this product out of reach of children
and animals. Do not use or store in or near open flame or heat.
Anipryl is intended for dogs with Canine
Cognitive Dysfunction Syndrome or Cushing's Disease stemming from a
pituitary gland tumor. Not for cats, other animals, or humans.
Do not give Anipryl to any dog that
does not have a prescription for it.
Use only as directed by your veterinarian.
CAUTION: Side effects may include
itching, diarrhea, vomiting, diminished appetite, drooling, sleep disturbances,
dry mouth, anemia, lethargy, disorientation, impaired hearing, restlessness,
mood changes, repetitive behaviors, uncontrollable movements, and shaking.
Talk to your veterinarian immediately
if you observe any adverse reaction in your pet.
Not for animals with a hypersensitivity
to selegiline. Some signs of an allergic reaction include facial swelling,
sudden-onset diarrhea, vomiting, difficulty breathing, pale gums, hives,
scratching, seizures, and coma. Seek emergency veterinary attention.
Mood swings, nervousness, inability
to sleep, headache, dizziness, hallucinations, seizures, weakness, or
perspiration are signs of an overdose. Take your pet for emergency veterinary
care if you suspect or know of an overdose.
The safety of Anipryl in pregnant,
nursing, and breeding dogs has not been determined.
Tell your veterinarian if your dog
takes meperidine or fluoxetine. Consult your veterinarian before giving
your pet any supplement or medication.
Warranty and Manufacturer Information:
For a copy of the Material Safety Data
Sheet (MSDS) or to report adverse reactions call Pfizer Animal Health
at 1-800-366-5288.
NADA #141-080, Approved by FDA
Manufactured by: DRAXIS Specialty Pharmaceuticals
Inc., Kirkland, QC, Canada H9H 4J4
Distributed by: Pfizer Animal Health,
Div. of Pfizer Inc, NY, NY 10017
75-0276-01
July 2005
Made in Canada
NAC No.: 36900002